Blocking CD47 promotes anti-tumor immunity through CD103+Dendritic Cell-NK Cell Axis in hepatocellular carcinoma

被引：0
|
作者：
Wang, S. [1 ]
机构：
[1] Zhejiang Shuren Univ, Dept Hepatobiliary & Pancreat Surg, Shulan Int Med Coll, Shulan Hangzhou Hosp, Hangzhou, Peoples R China
来源：
LIVER TRANSPLANTATION | 2024年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
eP-059
引用
收藏
页码：132 / 133
页数：2
相关论文
共 50 条
  • [31] IL-37 induces anti-tumor immunity by indirectly promoting dendritic cell recruitment and activation in hepatocellular carcinoma
    Liu, Yuan
    Zhao, Jing-Jing
    Zhou, Zi-Qi
    Pan, Qiu-Zhong
    Zhu, Qian
    Tang, Yan
    Xia, Jian-Chuan
    Weng, De-Sheng
    CANCER MANAGEMENT AND RESEARCH, 2019, 11 : 6691 - 6702
  • [32] EpCAM peptide-primed dendritic cell vaccination confers significant anti-tumor immunity in hepatocellular carcinoma cells
    Choi, Yoo Jin
    Park, Seong-Joon
    Park, You-Soo
    Park, Hee Sung
    Yang, Kwang Mo
    Heo, Kyu
    PLOS ONE, 2018, 13 (01):
  • [33] SIRPα-CD47 axis regulates dendritic cell-T cell interactions and TCR activation during T cell priming in spleen
    Autio, Anu
    Wang, Huan
    Velazquez, Francisco
    Newton, Gail
    Parkos, Charles A.
    Engel, Pablo
    Engelbertsen, Daniel
    Lichtman, Andrew H.
    Luscinskas, Francis W.
    PLOS ONE, 2022, 17 (04):
  • [34] Blockade of CD47 enhances the antitumor effect of macrophages in renal cell carcinoma through trogocytosis
    Park, Ha-Ram
    Kim, Seong-Eun
    Keam, Bhumsuk
    Chung, Hyewon
    Seok, Seung Hyeok
    Kim, Soyeon
    Kim, Miso
    Kim, Tae Min
    Doh, Junsang
    Kim, Dong-Wan
    Heo, Dae Seog
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [35] Blockade of CD47 enhances the antitumor effect of macrophages in renal cell carcinoma through trogocytosis
    Ha-Ram Park
    Seong-Eun Kim
    Bhumsuk Keam
    Hyewon Chung
    Seung Hyeok Seok
    Soyeon Kim
    Miso Kim
    Tae Min Kim
    Junsang Doh
    Dong-Wan Kim
    Dae Seog Heo
    Scientific Reports, 12
  • [36] IL-33 inhibits tumor growth through the activation of anti-tumor CD8+ T cell response in hepatocellular carcinoma
    Jin, Ziqi
    Liu, Haiyan
    JOURNAL OF IMMUNOLOGY, 2018, 200 (01):
  • [37] Erythromycin repurposing for hepatocellular carcinoma treatment: Targeting CD24 to enhance anti-tumor immunity
    Shao, Mingguang
    Zhao, Tiesuo
    Qian, Li
    Jia, Xiaolong
    Chen, Zhihan
    Wang, Kangle
    Sun, Yuanli
    Dong, Xiaoyu
    Geng, Jiaxin
    Zhang, Yongxi
    Guo, Sheng
    Yang, Zishan
    Wei, Tian
    Jia, Huijie
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2025, 998
  • [38] Trichosanthin Promotes Anti-Tumor Immunity through Mediating Chemokines and Granzyme B Secretion in Hepatocellular Carcinoma
    Wang, Kaifang
    Wang, Xiaona
    Zhang, Minghuan
    Ying, Zhenguang
    Zhu, Zeyao
    Tam, Kin Yip
    Li, Chunman
    Zhou, Guowei
    Gao, Feng
    Zeng, Meiqi
    Sze, Stephen Cho Wing
    Wang, Xia
    Sha, Ou
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (02)
  • [39] TLR3 Activation of Intratumoral CD103+ Dendritic Cells Modifies the Tumor Infiltrate Conferring Anti-tumor Immunity
    Roselli, Emiliano
    Araya, Paula
    Gonzalo Nunez, Nicolas
    Gatti, Gerardo
    Graziano, Francesca
    Sedlik, Christine
    Benaroch, Philippe
    Piaggio, Eliane
    Maccioni, Mariana
    FRONTIERS IN IMMUNOLOGY, 2019, 10
  • [40] CCL3 augments tumor rejection and enhances CD8+ T cell infiltration through NK and CD103+ dendritic cell recruitment via IFN
    Allen, Frederick
    Bobanga, Iuliana D.
    Rauhe, Peter
    Barkauskas, Deborah
    Teich, Nathan
    Tong, Caryn
    Myers, Jay
    Huang, Alex Y.
    ONCOIMMUNOLOGY, 2018, 7 (03):
12345